Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease

被引:0
|
作者
Waldemar, G.
Hyvarinen, M.
Wetterberg, P.
Korner, A.
Lehto, H.
Josiassen, M. K.
机构
[1] Rigshosp, Dept Neurol, DK-2100 Copenhagen, Denmark
[2] Loakso Hosp, Helsinki, Finland
[3] Medi 3 AS, Alesund, Norway
[4] Hosp Psychiat, Hillerod, Denmark
[5] H Lundbeck AB, Turku, Finland
[6] H Lundbeck & Co AS, Copenhagen, Denmark
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:188 / 188
页数:1
相关论文
共 50 条
  • [1] Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease
    Waldemar, Gunhild
    Hyvarinen, Maritta
    Josiassen, Mette Krog
    Korner, Alex
    Lehto, Heikki
    Wetterberg, Peter
    [J]. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2008, 23 (09) : 979 - 981
  • [2] Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
    Howard, Robert
    McShane, Rupert
    Lindesay, James
    Ritchie, Craig
    Baldwin, Ashley
    Barber, Robert
    Burns, Alistair
    Dening, Tom
    Findlay, David
    Holmes, Clive
    Hughes, Alan
    Jacoby, Robin
    Jones, Rob
    Jones, Roy
    McKeith, Ian
    Macharouthu, Ajay
    O'Brien, John
    Passmore, Peter
    Sheehan, Bart
    Juszczak, Edmund
    Katona, Cornelius
    Hills, Robert
    Knapp, Martin
    Ballard, Clive
    Brown, Richard
    Banerjee, Sube
    Onions, Caroline
    Griffin, Mary
    Adams, Jessica
    Gray, Richard
    Johnson, Tony
    Bentham, Peter
    Phillips, Patrick
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (10): : 893 - 903
  • [3] Effect of memantine treatment at patients with moderate-severe Alzheimer's disease treated with Donepezil
    Szalontay, A. S.
    Chirita, R.
    Chirita, V.
    [J]. EUROPEAN PSYCHIATRY, 2008, 23 : S198 - S198
  • [4] Memantine/donepezil dual therapy is superior to placebo/donepezil therapy for treatment of moderate to severe Alzheimer's disease
    Tariot, PN
    Farlow, MR
    Grossberg, G
    Gergel, I
    Graham, S
    Jin, J
    [J]. INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 289 - 289
  • [5] Memantine enhances autonomy in moderate to severe Alzheimer's disease patients already receiving donepezil
    Wirth, Y.
    Rive, B.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 474 - 474
  • [6] Effects of donepezil in patients with moderate-to-severe Alzheimer's disease discontinuing memantine monotherapy
    Sakka, P.
    Tsolaki, M.
    Hort, J.
    Hager, K.
    Soininen, H.
    Lopez-Pousa, S.
    Li, C.
    Schwam, E.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 58 - 58
  • [7] Memantine/donepezil dual-therapy is superior to placebo/donepezil therapy for treatment of moderate to severe Alzheimer's disease
    Grossberg, G
    Tariot, P
    Farlow, M
    Gergel, I
    Graham, S
    Jin, J
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S393 - S393
  • [8] Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil - A randomized controlled trial
    Tariot, PN
    Farlow, MR
    Grossberg, GT
    Graham, SM
    McDonald, S
    Gergel, I
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (03): : 317 - 324
  • [9] Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease
    Farlow, Martin
    Veloso, Felix
    Moline, Margaret
    Yardley, Jane
    Brand-Schieber, Elimor
    Bibbiani, Francesco
    Zou, Heng
    Hsu, Timothy
    Satlin, Andrew
    [J]. BMC NEUROLOGY, 2011, 11
  • [10] Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease
    Martin Farlow
    Felix Veloso
    Margaret Moline
    Jane Yardley
    Elimor Brand-Schieber
    Francesco Bibbiani
    Heng Zou
    Timothy Hsu
    Andrew Satlin
    [J]. BMC Neurology, 11